Article
Phenotypic differences and treatment persistence in a large multicentre cohort of axial psoriatic arthritis.
Rheumatology (Oxford, England) - 6 Apr 2026
Lopalco Giuseppe, Del Vescovo Sergio, Luchetti Michele Maria, Paci Valentino, Moroncini Gianluca, Ciccia Francesco, Gandolfo Saviana, Cauli Alberto, Floris Alberto, Cantarini Luca, Fabiani Claudia, Celletti Eleonora, Ricciardi Riccardo Mattia, Chimenti Maria Sole, Iacovantuono Maria, Guggino Giuliana, La Barbera Lidia, Guiducci Serena, Bozzalla Cassione Emanuele, Venerito Vincenzo, Baum Henriette, Torgutalp Murat, Iannone Florenzo, Proft Fabian
Abstract excerpt
OBJECTIVE: To compare clinical features across three axial psoriatic arthritis (PsA) phenotypes: (i) isolated axial PsA, (ii) axial PsA with oligoarticular involvement (axial PsA+oligo), and (iii) axial PsA with polyarticular disease (axial PsA+poly), and assess persistence of first-line biologic and targeted synthetic Disease-Modifying Anti-Rheumatic Drugs (b/tsDMARDs). METHODS: Baseline demographic, clinical,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
